semaglutide vs tirzepatide weight loss effectiveness semaglutide: which drug is easier to tolerate? ✨ Semaglutide vs. Tirzepatide —

semaglutide users at 12 months post-index, 0.5- and 1.0-mg formulations were the most common for both cohort 1 (38.9% and 56.0%, respectively) and cohort 2 (29.5% and 67.1%, respectively)

Discover evidence-based strategies to maintain your progress and explore how PlexusDx compounded semaglutide can provide continuity in your weight loss journey

No direct causal link has been established between GLP-1R use and increased aspiration risk

Provide direct home delivery of compounded tirzepatide for effortless weight loss.

Same-day virtual appointments and physician-guided GLP-1 weight-loss care from home.

Semaglutide was originally designed for type 2 diabetes, but clinical evidence shows it effectively reduces weight in people without diabetes